Paper150690
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).
Ludwig J and 2 others. Virchows Arch A Pathol Anat Histol, 1978. Cited by 664 papers, by iCite.
Cite this record
ConductScience Library. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Papers, record 150690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/150690
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver Cirrhosis, Biliary | Major topic |
| Adult | |
| Aged | |
| Biopsy | |
| Female | |
| Humans | |
| Liver | |
| Male | |
| Middle Aged | |
| Syndrome |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00244569 | Development of a Breath Test for Monitoring Patients With Liver Disease | Background |
Source ClinicalTrials.gov
References7
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14266218 | PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS. | Am J Pathol | 1965 | https://conductscience.org/library/papers/14266218 | PubMed |
| 2 | 5766764 | Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper. | Arch Pathol | 1969 | https://conductscience.org/library/papers/5766764 | PubMed |
| 3 | 13972306 | The problem of primary biliary cirrhosis. | Am J Med | 1962 | https://conductscience.org/library/papers/13972306 | PubMed |
| 4 | 6066569 | Primary biliary cirrhosis. | Proc R Soc Med | 1967 | https://conductscience.org/library/papers/6066569 | PubMed |
| 5 | 13982994 | Localization of the basic injury in primary biliary cirrhosis. | JAMA | 1963 | https://conductscience.org/library/papers/13982994 | PubMed |
| 6 | 323135 | A review of lobular, portal, and periportal hepatitis. Interpretation of biopsy specimens without clinical data. | Hum Pathol | 1977 | https://conductscience.org/library/papers/323135 | PubMed |
| 7 | 4908705 | Nonsuppurative destructive chronic cholangitis and chronic hepatitis. | Prog Liver Dis | 1970 | https://conductscience.org/library/papers/4908705 | PubMed |
Cited by177
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 664 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42871989 | Combined treatment of budesonide and ursodeoxycholic acid for non-cirrhotic primary biliary cholangitis: a systematic review and meta-analysis. | Hepatobiliary Surg Nutr | 2026 | https://conductscience.org/library/papers/42871989 | PubMed |
| 42842146 | Novel noninvasive technique for liver fibrosis evaluation using spatiotemporal analysis of strain elastography. | J Med Ultrason (2001) | 2026 | https://conductscience.org/library/papers/42842146 | PubMed |
| 42668455 | Bile Acid Profiles Define Disease-Specific Cholestatic States in Primary Sclerosing and Primary Biliary Cholangitis. | Gastro Hep Adv | 2026 | https://conductscience.org/library/papers/42668455 | PubMed |
| 42483735 | A Dual Time Window-driven Strategy to Optimize Primary Biliary Cholangitis Treatment via Alkaline Phosphatase Normalization. | J Clin Transl Hepatol | 2026 | https://conductscience.org/library/papers/42483735 | PubMed |
| 41956784 | [Impact of anti-gp210 and anti-centromere antibody dual positivity on clinical prognosis in patients with primary biliary cholangitis: risk analysis and establishment of response criteria]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/41956784 | PubMed |
| 41883439 | Abnormalities of liver sinusoidal endothelial cells in primary biliary cholangitis. | World J Exp Med | 2026 | https://conductscience.org/library/papers/41883439 | PubMed |
| 41868880 | Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis. | Ann Gastroenterol | 2026 | https://conductscience.org/library/papers/41868880 | PubMed |
| 41846257 | Primary Biliary Cholangitis Increases Mortality Irrespective of Presence or Absence of Cirrhosis. | Liver Int | 2026 | https://conductscience.org/library/papers/41846257 | PubMed |
| 41751398 | Somatostatin Effect on Growth Factors in Hepatocellular Carcinoma. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41751398 | PubMed |
| 41689244 | Plasma Biomarkers of Senescence in Cholestatic Liver Disease: A Signature of Risk Stratification and Progression. | J Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/41689244 | PubMed |
| 41680693 | Primary biliary cholangitis with inflammation involving zone 3 of the liver has a poor response to ursodeoxycholic acid treatment: a retrospective cohort study. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/41680693 | PubMed |
| 41669941 | Elevated Serum Soluble Tim-3 in Primary Biliary Cholangitis: Lack of Correlation with Cytokines, Chemokines, and Clinical Parameters. | Turk J Gastroenterol | 2025 | https://conductscience.org/library/papers/41669941 | PubMed |
| 41440960 | The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives. | J Pers Med | 2025 | https://conductscience.org/library/papers/41440960 | PubMed |
| 41257279 | Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis. | World J Gastroenterol | 2025 | https://conductscience.org/library/papers/41257279 | PubMed |
| 41023613 | Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis. | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/41023613 | PubMed |
| 40568038 | Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology. | World J Gastrointest Pathophysiol | 2025 | https://conductscience.org/library/papers/40568038 | PubMed |
| 39732944 | Development and external validation of an early prediction model to identify irresponsive patients and prognosis of UDCA treatment in primary biliary cholangitis. | Sci Rep | 2024 | https://conductscience.org/library/papers/39732944 | PubMed |
| 39704223 | Clinicopathologic Features of a Rare and Underrecognized Variant of Early-stage Primary Biliary Cholangitis With Ductopenia. | Am J Surg Pathol | 2025 | https://conductscience.org/library/papers/39704223 | PubMed |
| 39588121 | Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset? | Open Life Sci | 2024 | https://conductscience.org/library/papers/39588121 | PubMed |
| 39134906 | The relationship between CXCR6+CD8+T cells and clinicopathological parameters in patients with primary biliary cholangitis. | Hepatol Int | 2024 | https://conductscience.org/library/papers/39134906 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/150690
GET https://conductscience.org/api/papers/v1/150690/cited_by?page=2